You are here

Article info

Article menu
Download PDFPDF
Lung cancer
Original research
Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review

Authors

  1. Correspondence to Ms Shivani Setur Kanabar, Medical School, University of Birmingham College of Medical and Dental Sciences, Birmingham, Birmingham, UK; shivani.kanabar{at}outlook.com
View Full Text

Citation

Kanabar SS, Tiwari A, Soran V, et al
Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review
Thorax 2022;77:1163-1174.

Publication history

  • Received June 22, 2020
  • Accepted May 11, 2022
  • First published June 10, 2022.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.